157 related articles for article (PubMed ID: 37757956)
1. Comparison of the Effects of OPRM1 A118G Polymorphism Using Different Opioids: A Prospective Study.
Takemura M; Niki K; Okamoto Y; Kawamura T; Kohno M; Matsuda Y; Ikeda K
J Pain Symptom Manage; 2024 Jan; 67(1):39-49.e5. PubMed ID: 37757956
[TBL] [Abstract][Full Text] [Related]
2. The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone.
Boswell MV; Stauble ME; Loyd GE; Langman L; Ramey-Hartung B; Baumgartner RN; Tucker WW; Jortani SA
Pain Physician; 2013; 16(3):E227-35. PubMed ID: 23703421
[TBL] [Abstract][Full Text] [Related]
3. Opioids for cancer pain - an overview of Cochrane reviews.
Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
[TBL] [Abstract][Full Text] [Related]
4. Effects of the OPRM1 A118G Polymorphism (rs1799971) on Opioid Analgesia in Cancer Pain: A Systematic Review and Meta-Analysis.
Yu Z; Wen L; Shen X; Zhang H
Clin J Pain; 2019 Jan; 35(1):77-86. PubMed ID: 30028366
[TBL] [Abstract][Full Text] [Related]
5. Effects of OPRM1 A118G polymorphism on epidural analgesia with fentanyl during labor: a meta-analysis.
Song Z; Du B; Wang K; Shi X
Genet Test Mol Biomarkers; 2013 Oct; 17(10):743-9. PubMed ID: 23909491
[TBL] [Abstract][Full Text] [Related]
6. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone.
Takemura M; Niki K; Okamoto Y; Matsuda Y; Omae T; Takagi T; Ueda M
Biol Pharm Bull; 2021; 44(9):1286-1293. PubMed ID: 34471056
[TBL] [Abstract][Full Text] [Related]
7. Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain.
Gong XD; Wang JY; Liu F; Yuan HH; Zhang WY; Guo YH; Jiang B
Asian Pac J Cancer Prev; 2013; 14(5):2937-43. PubMed ID: 23803057
[TBL] [Abstract][Full Text] [Related]
8. Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population.
Bagher AM; Hareeri RH
J Appl Biomed; 2023 Sep; 21(3):160-165. PubMed ID: 37747315
[TBL] [Abstract][Full Text] [Related]
9. [Opioids for Cancer Pain and its Use under Particular Conditions: A Narrative Review].
Vieira C; Brás M; Fragoso M
Acta Med Port; 2019 May; 32(5):388-399. PubMed ID: 31166900
[TBL] [Abstract][Full Text] [Related]
10. The Influence of OPRM1 A118G Polymorphism on the Dosage of Morphine in Patients with Advanced Liver Cancer.
Cheng H; Chu X; Yi S
J Coll Physicians Surg Pak; 2021 Nov; 31(11):1375-1377. PubMed ID: 34689504
[TBL] [Abstract][Full Text] [Related]
11. Association between OPRM1 gene polymorphisms and fentanyl sensitivity in patients undergoing painful cosmetic surgery.
Fukuda K; Hayashida M; Ide S; Saita N; Kokita Y; Kasai S; Nishizawa D; Ogai Y; Hasegawa J; Nagashima M; Tagami M; Komatsu H; Sora I; Koga H; Kaneko Y; Ikeda K
Pain; 2009 Dec; 147(1-3):194-201. PubMed ID: 19783098
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype-genotype assessment.
Dunn KE; Huhn AS; Finan PH; Mange A; Bergeria CL; Maher BS; Rabinowitz JA; Strain EC; Antoine D
Addict Biol; 2024 Jan; 29(1):e13355. PubMed ID: 38221808
[TBL] [Abstract][Full Text] [Related]
13. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.
Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK
Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352
[TBL] [Abstract][Full Text] [Related]
14. Correlation between gene polymorphism and opioid efficacy in patients with gastric or intestinal cancer.
Pu J; Wang N; Huang ZK; He XY; Yuan HB
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9393-9410. PubMed ID: 31773688
[TBL] [Abstract][Full Text] [Related]
15. The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life.
Haupt LM; Haywood A; Sutherland HG; Yu C; Albury CL; Pharasi A; Zunk M; George R; Griffiths LR; Good P; Hardy J
Sci Rep; 2024 Feb; 14(1):3411. PubMed ID: 38341456
[TBL] [Abstract][Full Text] [Related]
16. [New Opioid Options in Japan - Methadone, Tapentadol and Hydromorphone].
Takagi Y; Aruga E
Gan To Kagaku Ryoho; 2018 Feb; 45(2):205-211. PubMed ID: 29483406
[TBL] [Abstract][Full Text] [Related]
17. Subjective health complaints in patients with lumbar radicular pain and disc herniation are associated with a sex - OPRM1 A118G polymorphism interaction: a prospective 1-year observational study.
Hasvik E; Iordanova Schistad E; Grøvle L; Julsrud Haugen A; Røe C; Gjerstad J
BMC Musculoskelet Disord; 2014 May; 15():161. PubMed ID: 24884878
[TBL] [Abstract][Full Text] [Related]
18. Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy.
Liu YC; Wang WS
Cancer; 2012 Mar; 118(6):1718-25. PubMed ID: 21837673
[TBL] [Abstract][Full Text] [Related]
19. Opioid Rotation in Cancer Pain Treatment.
Schuster M; Bayer O; Heid F; Laufenberg-Feldmann R
Dtsch Arztebl Int; 2018 Mar; 115(9):135-142. PubMed ID: 29563006
[TBL] [Abstract][Full Text] [Related]
20. Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Gálvez R; Schäfer M; Hans G; Falke D; Steigerwald I
Adv Ther; 2013 Mar; 30(3):229-59. PubMed ID: 23475406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]